OneMedNet Corporation and Navidence Inc. have entered into a strategic partnership that will embed Navidence’s Computable Operational Definitions (CODefs) into OneMedNet’s iRWD platform, which runs on Palantir Foundry. The integration will allow pharmaceutical and contract research organization customers to translate study criteria into executable queries more quickly and accurately, thereby accelerating evidence generation and regulatory submissions.
The partnership builds on OneMedNet’s expanding network, which now includes more than 2,130 healthcare sites—up from 1,402 sites reported in May 2024—providing a broader, regulatory‑grade data foundation for AI‑ready analytics. Navidence, founded in 2022, supplies standardized, executable queries that translate complex study protocols into a consistent, computable form across datasets, a capability that complements OneMedNet’s multimodal data platform.
The real‑world data market is projected to reach $6.37 billion by 2034, growing at a compound annual growth rate of roughly 14.5%. By integrating CODefs, OneMedNet aims to capture a larger share of this market, offering faster, more precise access to real‑world data for drugmakers, device manufacturers, and AI developers. The collaboration also supports OneMedNet’s shift toward a subscription‑based business model, which has already driven record bookings and a higher proportion of annual recurring revenue.
Aaron Green, OneMedNet’s CEO, said the partnership “provides a scalable, analytics‑enabled platform that meets the growing demand for reliable real‑world evidence.” The move is part of OneMedNet’s broader strategy to strengthen its position as a provider of regulatory‑grade, AI‑ready data and to deepen its relationship with Palantir Technologies.
The partnership is expected to streamline study design, reduce time to evidence, and enhance the precision of data queries—key competitive advantages in a market where speed and accuracy are critical for regulatory approval and post‑market surveillance. By combining Navidence’s CODefs with OneMedNet’s extensive data network, the companies aim to deliver a more efficient, end‑to‑end solution for real‑world evidence generation.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.